GlassScriptPhysician profile
Daniel Nathan Goldweit
NPI 1922366517
$2,492.75
in general payments reported to CMS, 2019-2025
13 companies · $260 in 2025
The $260 reported for 2025 was more than what 80% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.45 · 2020: $117 · 2021: $680 · 2022: $808 · 2023: $159 · 2024: $425 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acteon INC | $951.00 | 2020-2022 | |
| Implant Direct Sybron International LLC | $299.43 | 2021-2022 | |
| Dentsply Sirona INC | $293.71 | 2019-2025 | Mis, Implant Dentistry, Cavitron |
| Salvin Dental Specialties, INC. | $183.95 | 2021 | |
| Zimvie INC. | $148.90 | 2024 | |
| Ultradent Products INC | $124.54 | 2022 | |
| Align Technology, INC. | $124.49 | 2025 | Invisalign |
| Hu-Friedy Mfg. Co., LLC | $119.31 | 2024 | |
| Nobel Biocare USA | $97.33 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $86.72 | 2022-2025 | Arestin, Ossix Plus |
| Philips North America LLC | $34.19 | 2019-2025 | Oral Health Care Undivided |
| Shofu Dental Corp | $15.84 | 2022 | |
| Solventum Corporation | $13.34 | 2024 | 3m Relyx, 3m Scotchbond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Goldweit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.